Oventus Medical Limited

ASX:OVN Voorraadrapport

Marktkapitalisatie: AU$4.8m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Oventus Medical Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

John Cox

Algemeen directeur

AU$517.5k

Totale compensatie

Percentage CEO-salaris6.7%
Dienstverband CEO1.3yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn1.3yrs
Gemiddelde ambtstermijn bestuur4yrs

Recente managementupdates

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Oventus Medical Limited's (ASX:OVN) CEO For Now

Nov 11
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Oventus Medical Limited's (ASX:OVN) CEO For Now

Recent updates

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Oventus Medical Limited's (ASX:OVN) CEO For Now

Nov 11
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Oventus Medical Limited's (ASX:OVN) CEO For Now

Is Oventus Medical (ASX:OVN) In A Good Position To Invest In Growth?

May 09
Is Oventus Medical (ASX:OVN) In A Good Position To Invest In Growth?

Is Oventus Medical (ASX:OVN) In A Good Position To Invest In Growth?

Jan 24
Is Oventus Medical (ASX:OVN) In A Good Position To Invest In Growth?

Loss-Making Oventus Medical Limited (ASX:OVN) Expected To Breakeven In The Medium-Term

Nov 30
Loss-Making Oventus Medical Limited (ASX:OVN) Expected To Breakeven In The Medium-Term

Analyse CEO-vergoeding

Hoe is John Cox's beloning veranderd ten opzichte van Oventus Medical's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Dec 31 2021n/an/a

-AU$10m

Sep 30 2021n/an/a

-AU$10m

Jun 30 2021AU$517kAU$34k

-AU$10m

Compensatie versus markt: John's total compensation ($USD354.03K) is about average for companies of similar size in the Australian market ($USD282.66K).

Compensatie versus inkomsten: Insufficient data to compare John's compensation with company performance.


CEO

John Cox

1.3yrs

Tenure

AU$517,485

Compensatie

Mr. John Cox has been President and Chief Operating Officer of Oventus Medical Limited since June 7, 2021 and serves as its Chief Executive Officer since February 1, 2022. He serves as President and Chief...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
John Cox
CEO, President & COO1.3yrsAU$517.49kgeen gegevens
James Hunter
Acting Chief Financial Officer1.3yrsAU$202.85kgeen gegevens
Stephen Denaro
Company Secretary6.9yrsAU$63.05k0.14%
A$ 6.9k
Greg Eaton
Vice President Salesno datageen gegevensgeen gegevens

1.3yrs

Gemiddelde duur

Ervaren management: OVN's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Bestuursleden

NaamPositieTenureCompensatieEigendom
Richard Bogan
Member of Medical Technology Advisory Board4yrsgeen gegevensgeen gegevens
Jason Nunn
Non-Executive Director2.6yrsAU$194.84k0.15%
A$ 7.3k
Paul Molloy
Non-Executive Director2.8yrsAU$191.53k0.22%
A$ 10.4k
Susan MacLeman
Independent Non-Executive Chairman6.8yrsAU$162.29k0.093%
A$ 4.5k
Lee Surkin
Member of Medical Technology Advisory Board4yrsgeen gegevensgeen gegevens
Jerrold Kram
Member of Medical Technology Advisory Board4yrsgeen gegevensgeen gegevens
Mark Hickey
Member of Medical Technology Advisory Board4yrsgeen gegevensgeen gegevens
Mark Rasmus
Member of Medical Technology Advisory Board4yrsgeen gegevensgeen gegevens
Daniel Brown
Member of Medical Technology Advisory Board4yrsgeen gegevensgeen gegevens
Myra Brown
Member of Medical Technology Advisory Board4yrsgeen gegevensgeen gegevens
Pedro Cuartas
Medical Technology Advisory Board Member3.3yrsgeen gegevensgeen gegevens

4.0yrs

Gemiddelde duur

59yo

Gemiddelde leeftijd

Ervaren bestuur: OVN's board of directors are considered experienced (4 years average tenure).